USD 0.02
(-2.3%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | 2778.00 |
Gross Profit | - | - | - | - | - | -2778.00 |
Operating Expenses | 1.17 Million | 1.25 Million | 3.13 Million | 2.73 Million | 1.68 Million | 1.36 Million |
Selling, General and Administrative Expenses | 1.17 Million | 1.8 Million | 3.13 Million | 2.73 Million | 1.68 Million | 1.36 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | 550 Thousand | - | - | - | - |
Cost and Expenses | 1.17 Million | 1.25 Million | 3.13 Million | 2.73 Million | 1.68 Million | 1.37 Million |
Operating Income | -1.17 Million | -1.25 Million | -3.13 Million | -2.73 Million | -1.68 Million | -1.37 Million |
Interest Expense | 3.5 Million | 3.47 Million | 1.68 Million | 1.63 Million | 659.68 Thousand | - |
Income Tax Expense | -167.89 Thousand | -33.7 Thousand | -1684.52 | -1631.63 | -2.78 | -161.13 Thousand |
Earnings before Tax | -4.67 Million | -36.05 Million | -4.82 Million | -4.36 Million | -2.34 Million | -2.03 Million |
Net Income | -4.67 Million | -36.05 Million | -4.82 Million | -4.36 Million | -2.34 Million | -2.03 Million |
Earnings Per Share Basic | -0.01 | -0.10 | -0.01 | -0.02 | -0.01 | -0.02 |
Earnings Per Share Diluted | -0.01 | -0.10 | -0.01 | -0.02 | -0.01 | -0.02 |
Weighted Average Shares Outstanding | 401.42 Million | 345.54 Million | 343.91 Million | 273.92 Million | 163.68 Million | 128.09 Million |
Weighted Average Shares Outstanding (Diluted) | 401.42 Million | 345.54 Million | 343.91 Million | 273.92 Million | 163.68 Million | 128.09 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -1.17 Million | -1.25 Million | -3.13 Million | -2.73 Million | -1.68 Million | -1.72 Million |
Earnings Before Tax Margin | - | - | - | - | - | - |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - |
Operating Expenses | 225.94 Thousand | 204.55 | 179.88 Thousand | 208.3 Thousand | 1.17 Million | 286.51 Thousand |
Selling, General and Administrative Expenses | 225.94 Thousand | 204.55 | 179.88 Thousand | 208.3 Thousand | - | 286.51 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | 225.94 Thousand | 204.55 | 179.88 Thousand | 208.3 Thousand | 1.17 Million | 286.51 Thousand |
Operating Income | -225.94 Thousand | -204.55 | -179.89 Thousand | -208.3 Thousand | -1.17 Million | -286.51 Thousand |
Interest Expense | 8671.00 | 6717.00 | - | 945.26 Thousand | 3.5 Million | 903.09 Thousand |
Income Tax Expense | - | -204.55 Thousand | -43.27 Thousand | -43.81 Thousand | -167.89 Thousand | 39.58 Thousand |
Earnings before Tax | -234.61 Thousand | -211.27 | -179.88 Thousand | -1.15 Million | -4.67 Million | -1.18 Million |
Net Income | -234.61 Thousand | -211.27 | -179.88 Thousand | -1.15 Million | -4.67 Million | -1.18 Million |
Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | -0.00 | - | -0.00 |
Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | -0.00 | - | -0.00 |
Weighted Average Shares Outstanding | 401.42 Million | 401.64 Thousand | 401.42 Million | 401.42 Million | 401.42 Million | 401.42 Million |
Weighted Average Shares Outstanding (Diluted) | 401.42 Million | 406 Thousand | 401.42 Million | 401.42 Million | 401.42 Million | 401.42 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -225.94 Thousand | -204.55 Thousand | -179.89 Thousand | -208.3 Thousand | - | -286.51 Thousand |
Earnings Before Tax Margin | - | - | - | - | - | - |
EVER
CYTHW
6546
FLOMIC
GILADAFINS
BELCO